In AML, patients aged 81–100 have significantly lower levels of CD37 promoter methylation compared with patients aged 21–40, 41–60 and 61–80 (P=7.80E-04, P=3.02E-03, P=1.18E-03). The gene discussed is CD37; the disease is acute myeloid leukemia.